Send us Feedback

Protalix BioTherapeutics (PLX)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING 31-MAR
2012		 30-JUN
2012		 30-SEP
2012		 31-DEC
2012		 31-MAR
2013
Cash & Equivalents 45.6M 59.3M 50.2M 52.3M 41.9M
Short Term Investments 0 0 0 0 0
Accounts Receivable 815K 1.54M 7.31M 1.41M 1.70M
Inventories 263K 1.03M 2.06M 4.04M 5.77M
Pre-paid Expenses 0 0 0 251K 0
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 3.15M 4.04M 0 3.14M 3.55M
Total Current Assets 49.8M 65.9M 59.6M 61.2M 52.9M
Property, Plant & Equipment 17.5M 17.3M 16.7M 16.3M 15.7M
Goodwill & Intangibles 0 0 0 0 0
Other Long-term Assets 1.12M 1.07M 1.13M 1.25M 1.34M
Total Long-Term Assets 18.6M 18.4M 17.8M 17.6M 17.0M
Total Assets 68.5M 84.3M 77.4M 78.7M 69.9M
Accounts Payable 4.57M 4.51M 15.9M 6.83M 15.8M
Accrued Expenses 0 0 0 0 0
Short Term Debt 0 0 0 0 0
Other Current Liabilities 13.2M 16.8M 4.56M 15.1M 8.59M
Total Current Liabilities 17.7M 21.3M 20.4M 25.8M 24.4M
Long Term Debt 0 4.68M 0 0 0
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 57.2M 50.4M 52.2M 56.3M 51.8M
Total Long-term Liabilities 57.2M 55.1M 52.2M 56.3M 51.8M
Minority Interest 0 0 0 0 0
Total Liabilities 74.9M 76.4M 72.6M 82.1M 76.2M
Preferred Stock 0 0 0 0 0
Common Par 91.0K 92.0K 93.0K 93.0K 0
Additional Paid-In Capital 171M 176M 178M 180M 0
Retained Earnings -178M -168M -174M -184M 0
Treasury Stock 0 0 0 0 0
Other Equity 0 0 0 0 -6.28M
Total Shareholder's Equity -6.46M 7.86M 4.77M -3.36M -6.28M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki